Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Celularity ( (CELU) ) has issued an update.
On January 23, 2025, Celularity Inc. announced that its securities purchase agreement with an institutional investor expired due to non-receipt of the subscription amount, resulting in the cancellation of its planned private placement for common stock and warrants. This development may impact the company’s fundraising efforts and its financial strategy moving forward.
More about Celularity
Celularity Inc. operates in the biotechnology industry, focusing on developing cell therapies from placental-derived cells to treat cancer, infectious, and degenerative diseases.
YTD Price Performance: 4.55%
Average Trading Volume: 1,166,772
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $51.71M
See more data about CELU stock on TipRanks’ Stock Analysis page.